Linzess and Pharyngitis - a phase IV clinical study of FDA data

Summary:

Pharyngitis is reported as a side effect among people who take Linzess (linaclotide), especially for people who are female, 60+ old, also take Vitamin D3, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Pharyngitis when taking Linzess. It is created by eHealthMe based on reports of 23,558 people who have side effects when taking Linzess from the FDA, and is updated regularly.

What is Linzess?

Linzess has active ingredients of linaclotide. It is often used in constipation. eHealthMe is studying from 24,086 Linzess users. Check the latest studies of Linzess.

What is Pharyngitis?

Pharyngitis (inflammation of the pharynx, causing a sore throat) is found to be associated with 1,216 drugs and 1,210 conditions by eHealthMe. Check the latest studies of Pharyngitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

23,558 people reported to have side effects when taking Linzess.
Among them, 13 people (0.06%) have Pharyngitis.

Among these 13 people:

What is the gender of people who have Pharyngitis when taking Linzess? *

female: 100 %
male: 0.0 %

What is the age of people who have Pharyngitis when taking Linzess? *

What are other drugs people take besides Linzess? *

What are other side effects people have besides Pharyngitis? *

Infection: 9 people, 69.23%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 8 people, 61.54%
Otitis (ear infection): 8 people, 61.54%
Headache (pain in head): 8 people, 61.54%
Sinusitis (inflammation of sinus): 8 people, 61.54%
Fall: 7 people, 53.85%
Ear Congestion: 7 people, 53.85%
Movement - Uncoordinated: 6 people, 46.15%
Infusion Site Pain: 6 people, 46.15%
Neuropathy Peripheral (surface nerve damage): 6 people, 46.15%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 7 people, 53.85%
Primary Immunodeficiency Syndrome: 5 people, 38.46%
Asthma: 2 people, 15.38%
Sleep Disorder: 1 person, 7.69%
Muscle Function Loss: 1 person, 7.69%
Immune System Disorder: 1 person, 7.69%
Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 1 person, 7.69%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 7.69%
Hypersensitivity: 1 person, 7.69%
Breast Cancer: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Linzess and have Pharyngitis?

- Check whether Pharyngitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Linzess:

Linzess (24,086 reports)

Pharyngitis treatments and more:

Pharyngitis (21,038 reports)

Browse all side effects of Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pharyngitis:

Pharyngitis (1,216 drugs)

Browse all the conditions that are associated with Pharyngitis:

Pharyngitis (1,210 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on linaclotide (the active ingredients of Linzess) and Linzess (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.